Trial intelligence / Profile preview

EHOA: Etanercept as treatment for Hand Osteoarthritis

2007-003994-18Phase 3Active

Sponsor
Leiden University Medical Center
Start
Oct 2007
Modality
Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in hand osteoarthritis, erosive hand osteoarthritis (EHOA) and Finger osteoarthritis comparing Etanercept with Placebo (2 arms). Primary endpoint: Patient assessment of joint pain. Started Oct 2007; status: active.

02

Drugs

etanercept
03

Conditions

hand osteoarthritiserosive hand osteoarthritis (EHOA)Finger osteoarthritis

Beyond the preview

Go deeper on 2007-003994-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-003994-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call